Other
Therapeutics
0
Pipeline Programs↗
5
Active Trials↗
2
Companies Involved↗
Therapeutics is an early-stage landscape with 0 programs across 2 companies. The most active players are Prometic Biotherapeutics, Inc., AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed5 · 42%
Recruiting3 · 25%
Active, not recruiting2 · 17%
Terminated1 · 8%
Unknown status1 · 8%
Clinical Trials
Trial Activity
12 trials
Treatment of UC With Novel Therapeutics
Recruiting·—·Phase 2·NCT06420375·20 enrolled
Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.
Recruiting·—·N/A·NCT06369714·210 enrolled
Anhedonia, Development, and Emotions: Phenotyping and Therapeutics
Completed·—·Phase 4·NCT05487885·123 enrolled
The Economic Impact of Clinical Pharmacist Involvement in the Public Procurement for Medicines and in the Drug and Therapeutics Committee
Completed·—·N/A·NCT04314336·10,000 enrolled
Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1/2·NCT02363322·72 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)